Skip to main content

Boone Capital Management LLC

13F filer · CIK 0001882053
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$428MU.S. long equity reported on 13F
Positions167 new · 4 closed
Net flow last quarter+$75MBuys minus sells
Top 10 positions weight83.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202616 positions
TFXTeleflex Inc$49.1M11.49%0.88%+39.0%Q1 2026
MIRMMirum Pharmaceuticals, Inc.$48.7M11.38%0.64%-1.3%Q3 2023
CICigna Group$43.9M10.27%0.06%+15.8%Q4 2022
IONSIonis Pharmaceuticals Inc$41.2M9.64%0.31%+3.9%Q3 2025
UNHUnitedhealth Group Inc$36.9M8.62%0.01%+11.9%Q2 2025
BMRNBiomarin Pharmaceutical Inc$33.4M7.81%0.30%+6.5%Q1 2025
GRDNGuardian Pharmacy Services, Inc.$29.8M6.97%Not reported+12.8%Q1 2026
VSTSVestis Corp$27.6M6.45%1.44%NewQ2 2026
BBIOBridgeBio Pharma, Inc.$25.3M5.92%0.17%+48.5%Q3 2023
PNTGPennant Group, Inc.$19.1M4.46%1.48%Not reportedQ4 2023
GLUEMonte Rosa Therapeutics, Inc.$14.9M3.48%0.72%NewQ2 2026
KODKodiak Sciences Inc.$14.7M3.44%0.60%+34.4%Q3 2025
TNGXTango Therapeutics, Inc.$14.2M3.33%0.27%NewQ2 2026
KYMRKymera Therapeutics, Inc.$13M3.04%0.14%NewQ2 2026
CGEMCullinan Therapeutics, Inc.$12.8M3.00%1.09%NewQ2 2026
ANLAdlai Nortye Ltd.$2.97M0.70%Not reportedNewQ2 2026
Q1 2026Reported May 15, 202613 positions
MIRMMirum Pharmaceuticals, Inc.$38.9M11.92%0.69%Not reportedQ3 2023
IONSIonis Pharmaceuticals Inc$37.6M11.51%0.30%+19.8%Q3 2025
CICigna Group$36.7M11.24%0.05%+42.6%Q4 2022
MDTMedtronic plc$34.5M10.57%0.03%-7.2%Q1 2025
TFXTeleflex Inc$33.3M10.22%0.63%NewQ1 2026
BMRNBiomarin Pharmaceutical Inc$30.9M9.48%0.28%+33.0%Q1 2025
GRDNGuardian Pharmacy Services, Inc.$23.8M7.28%Not reportedNewQ1 2026
AZNAstrazeneca PLC$21.7M6.65%Not reported0.0%Q4 2025
UNHUnitedhealth Group Inc$21.4M6.57%0.01%+28.3%Q2 2025
BBIOBridgeBio Pharma, Inc.$17M5.21%0.12%+23.7%Q3 2023
AVNSAvanos Medical, Inc.$16.6M5.09%2.54%NewQ1 2026
KODKodiak Sciences Inc.$10.7M3.29%0.45%-44.2%Q3 2025
TENXTenax Therapeutics, Inc.$3.2M0.98%0.82%NewQ1 2026
Q4 2025Reported Feb 17, 202615 positions
MDTMedtronic plc$41.2M12.93%0.03%Not reportedQ1 2025
MIRMMirum Pharmaceuticals, Inc.$33.3M10.44%0.81%-21.4%Q3 2023
IONSIonis Pharmaceuticals Inc$33.1M10.37%0.26%Not reportedQ3 2025
CICigna Group$26.5M8.33%0.04%+16.3%Q4 2022
BMRNBiomarin Pharmaceutical Inc$24.5M7.68%0.21%+25.4%Q1 2025
NBIXNeurocrine Biosciences Inc$21.5M6.76%0.15%-8.8%Q2 2025
UNHUnitedhealth Group Inc$20.4M6.40%0.01%+6.3%Q2 2025
AZNAstrazeneca PLC$20.2M6.35%Not reportedNewQ4 2025
HQYHealthequity, Inc.$19.5M6.12%0.25%NewQ4 2025
LIVNLivaNova PLC$17.8M5.58%0.53%+72.0%Q3 2025
RAPTRAPT Therapeutics, Inc.$15.9M5.00%1.70%-39.9%Q3 2025
BBIOBridgeBio Pharma, Inc.$14.1M4.44%0.10%-59.8%Q3 2023
KODKodiak Sciences Inc.$14.1M4.42%0.82%-29.6%Q3 2025
TYRATyra Biosciences, Inc.$10.5M3.29%0.74%NewQ4 2025
WVEWave Life Sciences, Inc.$5.99M1.88%0.19%NewQ4 2025
Q3 2025Reported Nov 14, 202516 positions
MDTMedtronic plc$40.8M13.39%0.03%Not reportedQ1 2025
MIRMMirum Pharmaceuticals, Inc.$39.3M12.88%1.04%-16.5%Q3 2023
IONSIonis Pharmaceuticals Inc$27.3M8.96%0.26%NewQ3 2025
CICigna Group$23.9M7.84%0.03%+133.1%Q4 2022
BBIOBridgeBio Pharma, Inc.$23.9M7.84%0.24%Not reportedQ3 2023
NBIXNeurocrine Biosciences Inc$23.4M7.66%0.17%-7.7%Q2 2025
RAPTRAPT Therapeutics, Inc.$20.2M6.62%4.73%NewQ3 2025
UNHUnitedhealth Group Inc$20.1M6.58%0.01%Not reportedQ2 2025
BMRNBiomarin Pharmaceutical Inc$17.8M5.83%0.17%-26.6%Q1 2025
ICLRIcon PLC$16.8M5.50%0.13%Not reportedQ2 2025
COGTCogent Biosciences, Inc.$13.6M4.45%0.68%NewQ3 2025
KODKodiak Sciences Inc.$11.7M3.84%1.35%NewQ3 2025
LIVNLivaNova PLC$8.8M2.88%0.31%NewQ3 2025
QUREuniQure N.V.$8.6M2.82%0.24%NewQ3 2025
CLPTClearPoint Neuro, Inc.$6.19M2.03%1.00%NewQ3 2025
ABEOAbeona Therapeutics Inc.$2.66M0.87%0.96%-59.9%Q2 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.